1K5O
| CPI-17(35-120) deletion mutant | 分子名称: | CPI-17 | 著者 | Ohki, S, Eto, M, Kariya, E, Hayano, T, Hayashi, Y, Yazawa, M, Brautigan, D, Kainosho, M. | 登録日 | 2001-10-11 | 公開日 | 2002-10-11 | 最終更新日 | 2024-05-29 | 実験手法 | SOLUTION NMR | 主引用文献 | Solution NMR Structure of the Myosin Phosphatase Inhibitor Protein CPI-17 Shows Phosphorylation-induced Conformational Changes Responsible for Activation J.Mol.Biol., 314, 2001
|
|
1J2N
| Solution structure of CPI-17(22-120) T38D | 分子名称: | 17-kDa PKC-potentiated inhibitory protein of PP1 | 著者 | Ohki, S, Eto, M, Shimizu, M, Takada, R, Brautigan, D.L, Kainosho, M. | 登録日 | 2003-01-07 | 公開日 | 2003-06-17 | 最終更新日 | 2023-12-27 | 実験手法 | SOLUTION NMR | 主引用文献 | Distinctive Solution Conformation of Phosphatase Inhibitor CPI-17 Substituted with Aspartate at the Phosphorylation-site Threonine Residue J.Mol.Biol., 326, 2003
|
|
1J2M
| Solution structure of CPI-17(22-120) | 分子名称: | 17-kDa PKC-potentiated inhibitory protein of PP1 | 著者 | Ohki, S, Eto, M, Takada, R, Shimizu, M, Brautigan, D.L, Kainosho, M. | 登録日 | 2003-01-07 | 公開日 | 2003-06-17 | 最終更新日 | 2023-12-27 | 実験手法 | SOLUTION NMR | 主引用文献 | Distinctive Solution Conformation of Phosphatase Inhibitor CPI-17 Substituted with Aspartate at the Phosphorylation-site Threonine Residue J.Mol.Biol., 326, 2003
|
|